PanAgora Asset Management »

G1 Therapeutics shares owned by PanAgora Asset Management

Quarter-by-quarter ownership of G1 Therapeutics shares owned by PanAgora Asset Management from 13F filings

Historical chart of PanAgora Asset Management investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by PanAgora Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by PanAgora Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $404k 177k 2.28

More positions owned by PanAgora Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Coca-Cola Company (KO)
Wells Fargo & Company (WFC)
Mastercard Incorporated Cl A (MA)
Applied Materials (AMAT)
Eli Lilly & Co. (LLY)
Procter & Gamble Company (PG)
Visa Com Cl A (V)

View all positions for PanAgora Asset Management

Top funds holding G1 Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Qube Research & Technologies
Morgan Stanley
Bridgeway Capital Management
Two Sigma Investments
Two Sigma Advisers
Goldman Sachs Group
PanAgora Asset Management
Nuveen Asset Management
Alpine Partners VI
Alliancebernstein
Cetera Investment Advisers
Tower Research Capital

View all funds holding G1 Therapeutics